These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 2542966)
21. Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1. Aubert V; Schneeberger D; Sauty A; Winter J; Sperisen P; Aubert JD; Spertini F Infect Immun; 2000 Jan; 68(1):120-4. PubMed ID: 10603377 [TBL] [Abstract][Full Text] [Related]
22. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D; Yan Y; Ferguson K; O'Reilly RJ Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788 [TBL] [Abstract][Full Text] [Related]
23. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells. Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802 [TBL] [Abstract][Full Text] [Related]
24. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. Fuleihan R; Mourad W; Geha RS; Chatila T J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171 [TBL] [Abstract][Full Text] [Related]
25. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1. Shimonkevitz R; Boen E; Malmstrom S; Brown E; Hurley JM; Kotzin BL; Matsumura M Infect Immun; 1996 Apr; 64(4):1133-9. PubMed ID: 8606069 [TBL] [Abstract][Full Text] [Related]
27. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. von Bonin A; Ehrlich S; Malcherek G; Fleischer B Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089 [TBL] [Abstract][Full Text] [Related]
28. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821 [TBL] [Abstract][Full Text] [Related]
29. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498 [TBL] [Abstract][Full Text] [Related]
30. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1. Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671 [TBL] [Abstract][Full Text] [Related]
31. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. Braunstein NS; Weber DA; Wang XC; Long EO; Karp D J Exp Med; 1992 May; 175(5):1301-5. PubMed ID: 1569399 [TBL] [Abstract][Full Text] [Related]
32. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds. Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863 [TBL] [Abstract][Full Text] [Related]
33. Staphylococcal toxins bind to different sites on HLA-DR. Chintagumpala MM; Mollick JA; Rich RR J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373 [TBL] [Abstract][Full Text] [Related]
34. Bacterial superantigen signaling via HLA class II on human B lymphocytes. Mooney NA; Ju L; Brick-Ghannam C; Charron DJ Mol Immunol; 1994 Jun; 31(9):675-81. PubMed ID: 8028602 [TBL] [Abstract][Full Text] [Related]
35. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1. Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650 [TBL] [Abstract][Full Text] [Related]
36. A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles. Ramesh N; Spertini F; Scholl P; Geha R J Immunol; 1992 Feb; 148(4):1025-30. PubMed ID: 1737925 [TBL] [Abstract][Full Text] [Related]
37. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules. Spertini F; Spits H; Geha RS Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894 [TBL] [Abstract][Full Text] [Related]
38. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Karp DR; Jenkins RN; Long EO Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9657-61. PubMed ID: 1409679 [TBL] [Abstract][Full Text] [Related]
39. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. Wen R; Cole GA; Surman S; Blackman MA; Woodland DL J Exp Med; 1996 Mar; 183(3):1083-92. PubMed ID: 8642250 [TBL] [Abstract][Full Text] [Related]
40. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules. Rich RR; Mollick JA; Cook RG Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]